x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Investor Insights by seat11a: CEOs, Financial Results & Strategy Deep Dives

seat11a.com brings you brief, high-impact pitches directly from public companies" CEOs, CFOs, and Investor Relations. Each episode focuses on Financial Results, Elevator Pitches, and Deep Dives, offering key insights into business models, strategies, and performance metrics. Perfect for investors seeking quick, reliable updates across various sectors. Stay ahead with concise, expert-led presentations that enhance your investment decisions in just minutes. Join thousands of investors who

business investing

All Episodes

00:12:22

Carl Zeiss Meditec AG Financial Results Q1 2024/25 |...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/02/13

Sebastian Frericks, Head of Investor Relations atCarl Zeiss Meditec AG, presents theQ1 2024/25 financial results and discusses revenue growth, market challenges, and future strategies.At the start of the fiscal year,Carl Zeiss Meditec recorded a 3% revenue growth, primarily driven by theDOCTER OPTICS (DO) acquisition. However, underlyingorganic momentum remained negative, as anticipated. The company had previouslyguided for this decline in December, signalling a temporary headwind due to specific

en

00:04:26

Carl Zeiss Meditec AG Financial Results Q1 2024/25 |...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/02/12

CEO Presentation: Carl Zeiss Meditec AG Q1 2024/25 Financial PerformanceIn this comprehensive presentation, the CEO of Carl Zeiss Meditec AG delves into the company's performance during the first quarter of the 2024/25 fiscal year, highlighting a modest increase in revenue. The discussion begins with an overview of the financial results, where the CEO reports a slight revenue growth compared to the same period in the previous year. This growth is attributed to steady demand across key product lines

en

00:13:49

Carl Zeiss Meditec AG Elevator Pitch 2025 |...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/31

Carl Zeiss Meditec AG Elevator Pitch: Key TakeawaysCarl Zeiss Meditec AG: Market Leadership and Strategic Outlook Corporate Overview In this engaging elevator pitch, Sebastian Frericks, Head of Investor Relations at Carl Zeiss Meditec AG, provides a concise yet comprehensive introduction to the company’s equity story, market leadership, and growth potential. As one of the world’s leading medical technology companies, Carl Zeiss Meditec dominates the fields of ophthalmology and microsurgery,

en

00:11:07

BRAIN Biotech AG Financial Results FY 2023 / 24 |...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/30

BRAIN Biotech AG FY 2023/24: Key TakeawaysFinancial Performance OverviewDespite a challenging economic environment, BRAIN Biotech reported an adjusted EBITDA of €-0.4 million, a slight decrease from the previous year’s €+0.4 million. This resilience is a testament to the company’s strength and potential for future growth, especially given the substantial investments in the company’s BioIncubator projects. Schneiders emphasized the company’s strong cash position, stating, “With a strong focus on the

en

00:24:50

Carl Zeiss Meditec AG Company Presentation |...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/29

Introduction to Carl Zeiss Meditec AG by Sebastian Frericks, Head of Investor Relations Sebastian Frericks, Head of Investor Relations, delivered an engaging and insightful presentation on Carl Zeiss Meditec AG, a globally recognised leader in Ophthalmology and Microsurgery. This presentation comprehensively overviewed the company’s market position, key strategies, and future growth drivers. The company achieved €2,089 million in revenue in the 2023/24 fiscal year, with a historically solid EBIT

en

00:10:41

AIXTRON SE Company Presentation | Exploring Growth...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/26

AIXTRON SE Company Presentation: Key TakeawaysIntroduction to AIXTRON by Christian Ludwig, Head of Investor Relations and Corporate Communications Christian Ludwig, Head of Investor Relations and Corporate Communications at AIXTRON, delivers a concise yet powerful elevator pitch, highlighting the company’s impressive 40-year journey. AIXTRON has established itself as a trusted global technology leader in deposition systems, addressing transformative industries with cutting-edge solutions and a

en

00:14:42

Carl Zeiss Meditec AG Deep Dive Q&A | China and APAC...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/24

Carl Zeiss Meditec AG Deep Dive: Q&A Q&A with Carl Zeiss Meditec AG’s Head of Investor Relations, Sebastian Frericks China Market and Recovery Expectations Update on China’s Refractive Market and Recovery Expectations for 2024 Market Context: Carl Zeiss Meditec remains the leading player in China’s refractive laser surgery market, having experienced over a decade of growth at a CAGR exceeding 20%. However, since China’s reopening post-COVID in 2023, the market has faced challenges,

en

00:11:37

Carl Zeiss Meditec AG Deep Dive 2025 | US Market...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/19

Carl Zeiss Meditec AG Deep Dive: Q&AQ&A with Carl Zeiss Meditec AG’s Head of Investor Relations, Sebastian Frericks US Refractive Market Performance and Competitive Landscape Has refractive competition increased in 2024, particularly from J&J’s ELITA or Staar Surgical? - J&J’s ELITA: While J&J has entered some markets with their ELITA system, it has yet to gain significant traction in major markets like the US and China due to regulatory hurdles and limited product features

en

00:11:22

Carl Zeiss Meditec AG Deep Dive 2025 | Strategic...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/17

Carl Zeiss Meditec AG Deep Dive: Q&A Strategic Developments and Market Expansion at Carl Zeiss Meditec AG Overview Sebastian Frericks, Head of Investor Relations at Carl Zeiss Meditec AG, discusses the company’s strategic initiatives and recent acquisitions, focusing on the US market rollout of QUATERA 700, the impact of the DORC acquisition, and feedback on the integrated ZEISS cataract workflow. This comprehensive analysis underscores ZEISS’s efforts to expand its market potential and

en

00:04:11

AIXTRON SE Elevator Pitch 2025 | Powering the Future...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/15

AIXTRON SE Elevator Pitch: Key Takeaways Introduction to AIXTRON by Christian Ludwig, Head of Investor Relations and Corporate Communications Christian Ludwig, Head of Investor Relations and Corporate Communications at AIXTRON, delivers a concise yet powerful elevator pitch, highlighting the company’s impressive 40-year journey. AIXTRON has established itself as a trusted global technology leader in deposition systems, addressing transformative industries with cutting-edge solutions and a strong

en

00:10:33

Carl Zeiss Meditec AG Deep Dive 2025 | Financial...

Investor Insights by seat11a: CEOs, Financial Results... ·

2025/01/12

Carl Zeiss Meditec AG Deep Dive: Q&AFinancial and Strategic Outlook: Insights from Sebastian Frericks, Head of Investor Relations at Carl Zeiss Meditec AG US Equipment Sales and Market Dynamics Why Were US Equipment Sales, Especially in Microsurgery, Weak in Q3? Market Context: Weakness in microsurgery sales was driven by the late product cycle of older equipment and the launch of the new KINEVO 900 S neurosurgical platform in October 2024. Transition periods between product generations are

en

00:05:15

Carl Zeiss Meditec AG Financial Results FY 2023 /24 |...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/12/20

In this comprehensive financial presentation, Dr. Markus Weber, President and CEO, and Justus Felix Wehmer, CFO of Carl Zeiss Meditec AG, review the company's performance for the fiscal year 2023/24. The presentation addresses a slight revenue decline, the achievement of adjusted EBIT forecasts, and strategic initiatives aimed at future growth.Key Financial Highlights for Fiscal Year 2023/24 Revenue Performance Revenue slightly declined compared to the previous fiscal year, primarily due to

en

00:06:00

Kontron AG Financial Results 9M 2024 | IoT Growth...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/12/12

In this comprehensive financial presentation, Dr. Clemens Billek, Kontron AG's CFO, meticulously reviews the company's robust performance for the first nine months of 2024. The presentation underscores Kontron's impressive margin improvements, strategic growth initiatives, and formidable positioning in the Internet of Things (IoT) market, instilling confidence in the company's stability and growth potential.Key Financial Highlights for the First Nine Months of 2024Revenue and ProfitabilityRevenue:

en

00:15:51

RENK Group AG Financial Results 9M 2024 | Accelerated...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/12/02

In this comprehensive presentation, Christian Weiss, Head of Investor Relations at RENK Group AG, reviews the company’s financial performance for Q3 2024. The presentation highlights RENK’s robust growth trajectory, operational resilience, and strategic priorities, emphasizing its leadership in delivering advanced technology solutions for various industries.Introduction to RENK Group AG RENK Group AG, a trusted partner in mobility and power transmission technologies, demonstrated significant

en

00:16:18

eDreams ODIGEO Financial Results H1 2025 | Prime...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/11/25

IntroductionIn this comprehensive presentation, David Elizaga, CFO of eDreams ODIGEO, provides an in-depth review of the company’s financial results for the first half of FY25. The presentation highlights eDreams ODIGEO’s strong growth trajectory, driven by its innovative Prime subscription model, substantial profitability improvements, and strategic market positioning as a global travel subscription sector leader. Key Financial Highlights for 1H FY25 Strong Membership Growth Prime Members: They

en

00:06:45

Wacker Chemie AG Elevator Pitch | A Leader in...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/11/23

Introduction to Wacker Chemie Joerg Hoffmann introduces Wacker Chemie, a global leader in speciality chemical manufacturing. With over 16,000 employees, the company achieved an impressive €6.4 billion in sales and €824 million EBITDA in 2023, a testament to its exceptional performance. The company operates through four distinct business segments, each vitally involved in delivering innovative solutions to diverse industries worldwide. These segments are Silicones, Polymers, Polysilicon, and

en

00:19:25

Wacker Chemie AG Company Presentation | Market...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/11/21

Wacker Chemie AG Company Presentation: Key Takeaways Introduction to Wacker ChemieJoerg Hoffmann, Head of Investor Relations at Wacker Chemie AG, presented the company’s business model, core segments, markets, and strategies. Wacker Chemie, a leader in specialty chemicals and advanced materials, reported €6.4 billion in sales and €824 million in EBITDA for 2023, employing over 16,000 people globally. The company’s innovation, sustainability, and leadership across its four business

en

00:09:26

JOST Werke SE Financial Results 9M 2024 | Strategic...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/11/20

Podcast Description: JOST Werke SE 9M 2024 - Key Takeaways Introduction to JOST Werke SE In this comprehensive presentation, Romy Acosta, Head of Investor Relations at JOST Werke SE, delivers an in-depth analysis of the company’s financial performance for Q3 2024. The presentation highlights JOST’s resilience amid a cyclical market downturn, strategic milestones for long-term growth, and strong operational performance across regions and business segments. JOST Werke SE, a leading global manufacturer

en

00:08:07

Hypoport SE Financial Results 9M 2024 | Resilient...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/11/13

Hypoport SE 9M 2024: Key TakeawaysIn this comprehensive presentation, Ronald Slabke, CEO of Hypoport SE, provides an in-depth review of the company’s financial performance for the first nine months of 2024, highlighting Hypoport’s adaptability and resilience across key segments: Real Estate and Mortgage Platforms, Financing Platforms, and Insurance Platforms. Hypoport leverages its innovative platforms and market expertise despite challenging market conditions to drive growth and maintain

en

00:11:45

LEG Immobilien SE Financial Results 9M 2024 | Strong...

Investor Insights by seat11a: CEOs, Financial Results... ·

2024/11/09

In-depth Analysis of LEG Immobilien SE's Financial Results In this extensive and in-depth video presentation, Frank Kopfinger, Head of Investor Relations at LEG Immobilien SE, analyses the company's financial results for the first nine months of 2024. The presentation is packed with insights into LEG Immobilien's financial performance, operational efficiency, strategic initiatives, and future growth outlook, making it a must-watch for investors, analysts, and stakeholders interested in the real

en

407 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...